WEST PHARMACEUTICAL SERVICES INCWST

Market cap

$19.5B

P/E ratio

	Dec 31, 2010	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Net sales	-	-	-	-	-	-	-	-	-	2,147	2,832	2,887	2,950	2,893
Cost of goods and services sold	787	879	934	974	944	1,008	1,087	1,172	1,234	1,379	1,656	1,751	1,821	1,895
Gross profit	318	388	435	448	456	501	513	545	606	768	1,176	1,136	1,129	999
Research and development	24	33	38	37	34	37	39	40	39	47	53	59	68	69
Selling, General and Administrative Expense	188	218	235	229	233	240	243	263	273	302	363	317	353	339
Other expense (income) (Note 16)	-	-	-	0	-60	-28	-2	-2	3	-12	-8	-27	-31	-21
Operating profit	91	135	162	182	129	197	229	240	297	407	752	734	676	570
Interest expense	-	-	-	-	-	-	-	-	-	-	-	-	-	3
Interest income	1	2	2	4	2	1	1	2	4	1	1	5	28	20
Other nonoperating expense (income)	-	-	-	-	-	-	-	7	-0	1	4	-51	3	-1
Income before income taxes and equity in net income of affiliated companies	75	109	147	169	116	190	222	241	292	401	749	680	698	586
Income tax expense	14	33	40	47	26	54	81	41	59	73	107	115	122	108
Equity in net income of affiliated companies	4	5	5	5	6	8	9	8	9	17	20	21	18	15
Net income	65	81	112	127	96	144	151	207	242	346	662	586	593	493
Earnings Per Share, Basic	1.96	2.37	1.61	1.79	1.33	1.96	2.04	2.8	3.27	4.68	8.89	7.87	7.98	6.75
Earnings Per Share, Diluted	1.89	2.3	1.57	1.75	1.3	1.91	1.99	2.74	3.21	4.57	8.67	7.73	7.88	6.69